Genomic High-Throughput Proteonomic & DNA Profiling

We will characterize and assess every change in every gene in the entire human genome that is associated with and may cause each patient’s cancer. Similar analyses will occur for changes in proteins associated with and possible causing the cancer in question.

The field of proteomics strives to understand how proteins—the molecular entities that make up the major structural and functional components of cells and that drive physiological processes within all cells and tissues—relate to each other, and how that relation changes under altered physiological conditions, such as disease. Proteomics is thus the scientific discipline that strives to understand disease processes in terms of measuring the abundance, tissue localization, structure, function, modifications and molecular interactions proteins undergo as they regulate physiological processes, and how they may be altered during pathophysiology.

This is accomplished in many different ways under many different research scenarios, but it often employs workflow strategies and technology platforms that require various suitable protein isolation techniques followed by protein/peptide-level separation technologies and mass spectrometry to help identify and quantify proteins isolated from biological samples and tissues

Current Program Infrastructure, Including Human and Technological Resources
The Proteomics Lab is set up to offer a wide array of services for typical proteomic analysis needs. These services and proteomic workflows are primarily set up around liquid chromatography-mass spectrometry (LC/MS) instrumentation platforms. These, along with associated sophisticated data analysis software and computational platforms and database search engines, form the basis of the Lab’s existing technology offerings. The Lab provides a full complement of scientific support in addition to its analytical instrumentation service capabilities—meaning its scientists are involved with the investigator from the experimental design phase of a study all the way through to data analysis and interpretation at all levels of proteomic research.

Kenneth R. Peak Brain and Pituitary Tumor Treatment & Research Center 
Houston Methodist Hospital - Texas Medical Center
6445 Main Street, Outpatient Center, Floor 24
Houston, TX 77030